JMP Securities maintains PTGX stock with $58 target
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
Affirm stock price target raised to $85 at JMP Securities
JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...
JMP Securities Keeps Their Buy Rating on Sprinklr (CXM)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr (CXM – Research Report) today and set a price target of $17.00.
JMP Securities Remains a Hold on Boyd Gaming (BYD)
JMP Securities analyst Jordan Bender maintained a Hold rating on Boyd Gaming (BYD – Research Report) today. The company’s shares closed ...
Roku, Inc. (ROKU): Among Cathie Wood’s Top Stock Picks for 2025
Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...
Xometry appoints new CTO as Leibel departs
Mr. Leibel's departure, as stated in the company's SEC filing, is not due to any disagreements or disputes with the company's operations or practices. He will continue to serve as an employee until ...
Unity Software’s (U) Market Perform Rating Reiterated at JMP Securities
Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...